Recent advances in Wilms tumor genetics

被引:91
作者
Dome, JS
Coppes, MJ
机构
[1] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
[2] Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38105 USA
[3] Univ Calgary, Childrens Canc Program, Tom Baker Canc Ctr, Calgary, AB, Canada
[4] Univ Calgary, Alberta Childrens Hosp, Calgary, AB, Canada
[5] Univ Calgary, Dept Oncol, Calgary, AB, Canada
[6] Univ Calgary, Dept Pediat, Calgary, AB, Canada
关键词
D O I
10.1097/00008480-200202000-00002
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The past decade has witnessed substantial growth in our knowledge of the genes and loci that are altered in Wilms tumor. Although Wilms tumor was one of the original paradigms of Knudson's two-hit model of cancer formation, it has become apparent that several genetic events contribute to Wilms tumorigenesis. Recent research has identified targets and regulators of the first Wilms tumor gene, WT1, has uncovered several candidate genes at the second Wilms tumor locus, WT2, and has identified two familial Wilms tumor loci, FWT1 and FWT2. The recent discovery of activating beta-catenin mutations in some Wilms tumors has also implicated the Wnt signaling pathway in this neoplasm. Recurrent abnormalities of other loci, including 16q, 1p, and 7p, have indicated that these sites may harbor Wilms tumor genes. An enhanced understanding of these and other genetic lesions will provide the foundation for novel targeted Wilms tumor therapies. (C) 2002 Lippincott Williams Wilkins, Inc.
引用
收藏
页码:5 / 11
页数:7
相关论文
共 99 条
  • [1] Arcellana-Panlilio MY, 2000, GENE CHROMOSOME CANC, V29, P63, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1006>3.0.CO
  • [2] 2-L
  • [3] Donor splice-site mutations in WT1 are responsible for Frasier syndrome
    Barbaux, S
    Niaudet, P
    Gubler, MC
    Grunfeld, JP
    Jaubert, F
    Kuttenn, F
    Fekete, CN
    SouleyreauTherville, N
    Thibaud, E
    Fellous, M
    McElreavey, K
    [J]. NATURE GENETICS, 1997, 17 (04) : 467 - 470
  • [4] BARDEESY N, 1995, CANCER RES, V55, P215
  • [5] ANAPLASTIC WILMS-TUMOR, A SUBTYPE DISPLAYING POOR-PROGNOSIS, HARBORS P53 GENE-MUTATIONS
    BARDEESY, N
    FALKOFF, D
    PETRUZZI, MJ
    NOWAK, N
    ZABEL, B
    ADAM, M
    AGUIAR, MC
    GRUNDY, P
    SHOWS, T
    PELLETIER, J
    [J]. NATURE GENETICS, 1994, 7 (01) : 91 - 97
  • [6] Barker N, 2000, BIOESSAYS, V22, P961
  • [7] Baudry D, 2000, CLIN CANCER RES, V6, P3957
  • [8] BECKWITH J B, 1990, Pediatric Pathology, V10, P1
  • [9] Beniers AJMC, 2001, INT J ONCOL, V18, P133
  • [10] Relative frequency and morphology of cancers in carriers of germline TP53 mutations
    Birch, JM
    Alston, RD
    McNally, RJQ
    Evans, DGR
    Kelsey, AM
    Harris, M
    Eden, OB
    Varley, JM
    [J]. ONCOGENE, 2001, 20 (34) : 4621 - 4628